Tags

Type your tag names separated by a space and hit enter

Ligand-Controlled Diastereoselective Cobalt-Catalysed Hydroalkynylation of Terminal Alkynes to E- or Z-1,3-Enynes.
Chemistry. 2020 Sep 21; 26(53):12129-12133.C

Abstract

A diastereoselective hydroalkynylation of terminal alkynes to form the head-to-head dimerization products by two different cobalt-phosphine catalyst system is reported. The use of the bidentate ligand dppp and additional triphenylphosphine led to the selective formation of the (E)-1,3-enynes (E:Z>99:1) in good to excellent yields, while the tridentate ligand TriPhos led to the corresponding (Z)-1,3-enynes in moderate to good yields with excellent stereoselectivities (up to E:Z=1:99). Both pre-catalysts are easy to handle, because of their stability under atmospheric conditions. The optimized reaction conditions were identified by the Design of Experiments (DoE) approach, which has not been used before in cobalt-catalysed reaction optimisation. DoE decreased the number of required reactions to a minimum.

Authors+Show Affiliations

Institut für Chemie, Carl von Ossietzky Universität Oldenburg, Carl-von-Ossietzky Straβe 9-11, 26129, Oldenburg, Germany. Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Straβe 4, 35043, Marburg, Germany.Institut für Chemie, Carl von Ossietzky Universität Oldenburg, Carl-von-Ossietzky Straβe 9-11, 26129, Oldenburg, Germany.Institut für Chemie, Carl von Ossietzky Universität Oldenburg, Carl-von-Ossietzky Straβe 9-11, 26129, Oldenburg, Germany.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32271963

Citation

Weber, Sebastian M., et al. "Ligand-Controlled Diastereoselective Cobalt-Catalysed Hydroalkynylation of Terminal Alkynes to E- or Z-1,3-Enynes." Chemistry (Weinheim an Der Bergstrasse, Germany), vol. 26, no. 53, 2020, pp. 12129-12133.
Weber SM, Queder J, Hilt G. Ligand-Controlled Diastereoselective Cobalt-Catalysed Hydroalkynylation of Terminal Alkynes to E- or Z-1,3-Enynes. Chemistry. 2020;26(53):12129-12133.
Weber, S. M., Queder, J., & Hilt, G. (2020). Ligand-Controlled Diastereoselective Cobalt-Catalysed Hydroalkynylation of Terminal Alkynes to E- or Z-1,3-Enynes. Chemistry (Weinheim an Der Bergstrasse, Germany), 26(53), 12129-12133. https://doi.org/10.1002/chem.202001697
Weber SM, Queder J, Hilt G. Ligand-Controlled Diastereoselective Cobalt-Catalysed Hydroalkynylation of Terminal Alkynes to E- or Z-1,3-Enynes. Chemistry. 2020 Sep 21;26(53):12129-12133. PubMed PMID: 32271963.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ligand-Controlled Diastereoselective Cobalt-Catalysed Hydroalkynylation of Terminal Alkynes to E- or Z-1,3-Enynes. AU - Weber,Sebastian M, AU - Queder,Jona, AU - Hilt,Gerhard, Y1 - 2020/09/07/ PY - 2020/04/08/received PY - 2020/4/10/pubmed PY - 2020/4/10/medline PY - 2020/4/10/entrez KW - alkynes KW - cobalt KW - enynes KW - hydroalkynylation KW - stereoselectivity SP - 12129 EP - 12133 JF - Chemistry (Weinheim an der Bergstrasse, Germany) JO - Chemistry VL - 26 IS - 53 N2 - A diastereoselective hydroalkynylation of terminal alkynes to form the head-to-head dimerization products by two different cobalt-phosphine catalyst system is reported. The use of the bidentate ligand dppp and additional triphenylphosphine led to the selective formation of the (E)-1,3-enynes (E:Z>99:1) in good to excellent yields, while the tridentate ligand TriPhos led to the corresponding (Z)-1,3-enynes in moderate to good yields with excellent stereoselectivities (up to E:Z=1:99). Both pre-catalysts are easy to handle, because of their stability under atmospheric conditions. The optimized reaction conditions were identified by the Design of Experiments (DoE) approach, which has not been used before in cobalt-catalysed reaction optimisation. DoE decreased the number of required reactions to a minimum. SN - 1521-3765 UR - https://www.unboundmedicine.com/medline/citation/32271963/Ligand_Controlled_Diastereoselective_Cobalt_Catalysed_Hydroalkynylation_of_Terminal_Alkynes_to_E__or_Z_13_Enynes_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.